Clinical Trials Browser

Terminated × INDUSTRY × anetumab ravtansine × Clear all

NCT03926143 2023-08-04

A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies

Phase 2 Terminated

9 enrolled 10 charts

Other solid neoplasmThoracic

Mesothelioma